A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

• Status: Completed
• Trial end date: 2006-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Bromides; Formoterol Fumarate; Tiotropium Bromide

Criteria

Inclusion Criteria:

• Medical diagnosis of COPD

• Current or prior history of cigarette smoking

Exclusion Criteria:

• Medical diagnosis of asthma

• Significant condition or disease other than COPD